Countervail Corporation


European patent for the use of galantamine as Method of Treating Organophosphorus Poisoning was granted and registered in Germany, Italy, France, UK, Spain, Turkey, Austria, Poland and Sweden.

The awarded patent broadly covers the use of galantamine as a medical countermeasure to all organophosphorus (OP) compounds to include military nerve agents such as sarin and OP pesticides such as malathion and diazinon.